RibbonCare AI — Product Whitepaper

⏱

⚖

⚠

Taplin et al., 2002 — JNCI [1]

📋

💖

01

02

03

04

05

06

100%

< 1S

0

Taiwan

~920,000 / yr

9.1%

HPA / ACR

Source: HPA 2025; Yao et al. BMC Medicine 2023

Japan

~4.7M / yr

8.1%

MHLW / J-START

Source: MHLW Comprehensive Survey 2019; JMA Journal 2024

United States

USA

~40.5M / yr

10.6%

FDA MQSA

Source: FDA MQSA National Statistics 2023

Singapore

~180,000 / yr

~10%

HPB / BSS

Source: EurekAlert/NUS 2025; BreastScreen SG

Vietnam

N/A

MOH

Source: PLOS One 2018; JCO Global Oncology 2024

Malaysia

~5%

MOH CPG

Source: BMC Public Health 2023; Cancer Research MY

Luxembourg

~35,000 / yr

~5%

EU Guidelines

Source: Luxembourg Gov 2024; Eurostat; LIH Report

Thailand

N/A

NCI Thailand

Source: NHSO Thailand 2024; Korean J Radiol 2025

0

2,000

Hologic Selenia Dimensions

2,004

SIEMENS Mammomat Inspiration 73%
+ Revelation 26%

1,829

Hologic Selenia Dimensions 74%
+ Lorad Selenia 25%

1,842

SIEMENS Mammomat Inspiration

Sensitivity

0%

Specificity

0%

Accuracy

0%

23.3 LR+

<200

9.40%

3.00%

0.25%

0.15%

🏥

1

2

3

4

5

6

7

8

9

10

Clinical Mammography Workflow

1

2

3

Real-time QC

4

Real-time QC

5

6

7

🖥

🔌

🔒

✅

●
●
●
●
●


	93.0%	90.1 – 95.2%
	96.0%	95.3 – 96.6%
	95.0%	94.4 – 95.6%
	23.3	—
	0.073	—

n		Cohen's κ	McNemar p
7,675	95.0%	0.83	p=0.21 (ns)
3,882	92.4%	0.81	p=0.34 (ns)
7,675	96.5%	0.85	p=0.62 (ns)
3,882	84.1%	0.72	p=0.74 (ns)
7,675	89.3%	0.76	p=0.08 (ns)
7,675	97.7%	0.88	p=0.15 (ns)
3,882	65.9%	0.45	p<.001***

Medical Center A

9.40%

Medical Center B

3.00%

Medical Center C

0.25%

Medical Center D

0.15%

<1

●
●
●


	Apple Mac mini M4 Pro (12-core CPU / 16-core GPU / 24 GB RAM / 512 GB SSD)
	Gechic T151A 15.6"

Mammography Unit

DICOM

HUB / Switch

Ethernet

PACS

Ethernet

RibbonCare Edge

Mac mini M4 Pro + Touch Display

✓

●
●
●
●
●

🔒
🔒
🔒
🔒
🔒

✓ IEC 62304

✓ ISO 14971

✓ ISO 13485

✓ GDPR Ready


		✓
		✓
		✓
		✓
		✓
		✓
		✓
		✓
		✓

Source: 衛福部負責任AI執行中心, 2025

Taplin SH, et al. "Screening mammography: clinical image quality and the risk of interval breast cancer." AJR, 2002. pubmed.ncbi.nlm.nih.gov/12034942
Taiwan HPA. Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004-2020. BMC Medicine, 2023. bmcmedicine.biomedcentral.com
Taiwan HPA — Qualification Review & Quality Monitoring Principles for Mammography Institutions (revised June 2024). hpa.gov.tw
Ohuchi N, et al. J-START: Sensitivity and specificity of mammography and adjunctive ultrasonography. Lancet, 2016. pmc.ncbi.nlm.nih.gov
FDA MQSA National Statistics — 2023 estimated 40.5M mammography examinations. fda.gov/MQSA
Singapore Health Promotion Board — BreastScreen Singapore programme (2002-present). hpb.gov.sg
Nguyen LH, et al. Cost-effectiveness of breast cancer screening using mammography in Vietnamese women. PLOS One, 2018. journals.plos.org
Yip CH, et al. Breast Cancer Screening in Malaysia: A Policy Review. Asian Pac J Cancer Prev, 2021. pmc.ncbi.nlm.nih.gov
Luxembourg Ministry of Health — Programme Mammographie (2024 extension to age 45-74). gouvernement.lu
Thailand NHSO — Mammography & ultrasound screening for high-risk women benefit package, 2024. eng.nhso.go.th
Breast Cancer Screening in Asian Countries: Epidemiology, Screening Practices, Outcomes, Challenges, and Future Directions. Korean J Radiol, 2025. pmc.ncbi.nlm.nih.gov
AJR — Effects of QA Regulatory Enforcement on Performance of Mammography Systems in Taiwan. ajronline.org